Stonepine Capital Management, LLC

Holdings History for Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Symbol: APRE on Nasdaq
Investment type: Equity / Common stock, par value $0.001 per share
Latest Disclosed Shares Owned: 239,416 shares
Security Ownership %: 4.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Stonepine Capital Management, LLC ownership in Aprea Therapeutics, Inc. Common stock, par value $0.001 per share (APRE)

14 May 2025 - Stonepine Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 239,416 shares of Aprea Therapeutics, Inc. Common stock, par value $0.001 per share (APRE). This represents 4.3% ownership of the company. In their previous filing dated 13 Feb 2025, Stonepine Capital Management, LLC had reported owning 286,395 shares, indicating a decrease of +16%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Stonepine Capital Management, LLC	4.3%	-16%	$418,978	239,416	-46,979	-16%	$1.75	13G/A	31 Mar 2025	14 May 2025, 16:04
Stonepine Capital Management, LLC	5.1%		$501,191	286,395			$1.75	13G/A	31 Dec 2024	13 Feb 2025, 12:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2025		0%	$14,400	102,242	0		$0.14 ^*	Q1 2025
31 Dec 2024	0.4%	+0.03%	$490,937	149,221	+12,047	+8.8%	$3.29	Q4 2024
30 Sep 2024	0.24%	0%	$377,229	137,174	0		$2.75	Q3 2024
30 Jun 2024	0.51%	+0.51%	$558,298	137,174	+137,174	NEW	$4.07	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.